<?xml version="1.0" encoding="UTF-8"?>
<p id="P44">Vidarabine, a purine nucleoside obtained from 
 <italic>Streptomyces antibioticus,</italic> was historically used for treating HSV and VZV. Acyclovir has since become the preferred drug for these conditions.
 <sup>
  <xref ref-type="bibr" rid="R90">90</xref>
 </sup> Vidarabine is currently available only as an ophthalmic solution for treating recurrent epithelial keratitis and acute keratoconjunctivitis.
 <sup>
  <xref ref-type="bibr" rid="R90">90</xref>
 </sup> Once phosphorylated into its active form, vidarabine inhibits viral DNA polymerase. Adverse effects of ophthalmic vidarabine include irritation, pain, photophobia, lacrimation, and occlusion of the lacrimal duct.
 <sup>
  <xref ref-type="bibr" rid="R90">90</xref>
 </sup>
</p>
